ARMISTICE CAPITAL, LLC - Q2 2017 holdings

$785 Million is the total value of ARMISTICE CAPITAL, LLC's 59 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 80.9% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$135,408,000
+105.1%
560,000
+100.0%
17.26%
+26.6%
VNDA BuyVANDA PHARMACEUTICALS INC$33,643,000
+49.4%
2,064,000
+28.4%
4.29%
-7.8%
DECK BuyDECKERS OUTDOOR CORPcall$27,304,000
+357.1%
400,000
+300.0%
3.48%
+182.2%
DEPO NewDEPOMED INC$26,120,0002,432,000
+100.0%
3.33%
HAIN BuyHAIN CELESTIAL GROUP INC$26,087,000
+71.9%
672,000
+64.7%
3.32%
+6.1%
CPB NewCAMPBELL SOUP COcall$25,032,000480,000
+100.0%
3.19%
FRPT SellFRESHPET INC$22,111,000
+36.2%
1,332,000
-9.8%
2.82%
-16.0%
REGN BuyREGENERON PHARMACEUTICALS$21,610,000
+39.4%
44,000
+10.0%
2.75%
-14.0%
NOMD BuyNOMAD FOODS LTD$20,544,000
+59.6%
1,456,000
+29.5%
2.62%
-1.5%
ADMS BuyADAMAS PHARMACEUTICALS INC$20,253,000
+33.9%
1,158,000
+34.0%
2.58%
-17.3%
PII BuyPOLARIS INDS INC$19,922,000
+80.1%
216,000
+63.6%
2.54%
+11.2%
TPX BuyTEMPUR SEALY INTL INC$18,687,000
+35.9%
350,000
+18.2%
2.38%
-16.1%
ATRS SellANTARES PHARMA INC$18,354,000
-25.7%
5,700,000
-34.5%
2.34%
-54.2%
NVLNF  NOVELION THERAPEUTICS INC$17,094,000
-14.1%
1,852,0000.0%2.18%
-46.9%
ENR NewENERGIZER HLDGS INC NEW$16,807,000350,000
+100.0%
2.14%
SEAS BuySEAWORLD ENTMT INC$16,270,000
+85.5%
1,000,000
+108.3%
2.07%
+14.5%
PLYA NewPLAYA HOTELS & RESORTS NV$14,938,0001,250,000
+100.0%
1.90%
HBI SellHANESBRANDS INC$13,896,000
-4.4%
600,000
-14.3%
1.77%
-41.0%
MNTA NewMOMENTA PHARMACEUTICALS INC$13,858,000820,000
+100.0%
1.77%
GCI NewGANNETT CO INC$13,394,0001,536,000
+100.0%
1.71%
AVDL BuyAVADEL PHARMACEUTICALS PLCsponsored adr$12,685,000
+37.1%
1,150,000
+20.3%
1.62%
-15.4%
ALXN SellALEXION PHARMACEUTICALS INC$12,167,000
-5.3%
100,000
-5.7%
1.55%
-41.6%
SBBP BuySTRONGBRIDGE BIOPHARMA PLC$12,098,000
+55.3%
1,692,000
+3.2%
1.54%
-4.2%
QRTEA NewLIBERTY INTERACTIVE CORP$11,485,000468,000
+100.0%
1.46%
BBY BuyBEST BUY INC$11,466,000
+55.5%
200,000
+33.3%
1.46%
-4.0%
ANF BuyABERCROMBIE & FITCH COcl a$11,196,000
+108.5%
900,000
+100.0%
1.43%
+28.7%
BBBY NewBED BATH & BEYOND INC$10,701,000352,000
+100.0%
1.36%
FTDCQ BuyFTD COS INC$10,560,000
+4.9%
528,000
+5.6%
1.35%
-35.3%
RXDX SellIGNYTA INC$10,350,000
-19.0%
1,000,000
-32.7%
1.32%
-50.0%
DG NewDOLLAR GEN CORP NEW$10,093,000140,000
+100.0%
1.29%
TSN NewTYSON FOODS INCcl a$10,021,000160,000
+100.0%
1.28%
HZNP SellHORIZON PHARMA PLC$9,733,000
-22.5%
820,000
-3.5%
1.24%
-52.2%
AET BuyAETNA INC NEW$9,717,000
+52.4%
64,000
+28.0%
1.24%
-6.0%
LOCO BuyEL POLLO LOCO HLDGS INC$9,695,000
+24.8%
700,000
+7.7%
1.24%
-22.9%
ENTA SellENANTA PHARMACEUTICALS INC$9,499,000
+13.4%
264,000
-2.9%
1.21%
-30.0%
SGYPQ SellSYNERGY PHARMACEUTICALS DEL$8,900,000
-15.1%
2,000,000
-11.1%
1.13%
-47.6%
JCPNQ NewPENNEY J C INC$8,370,0001,800,000
+100.0%
1.07%
ALIM BuyALIMERA SCIENCES INC$8,201,000
+32.1%
5,900,000
+33.0%
1.04%
-18.5%
 PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0$7,053,000
+4.6%
22,760,0000.0%0.90%
-35.5%
CRI NewCARTER INC$6,938,00078,000
+100.0%
0.88%
PINC NewPREMIER INCcl a$6,552,000182,000
+100.0%
0.84%
ANF NewABERCROMBIE & FITCH COcall$6,220,000500,000
+100.0%
0.79%
OPHT NewOPHTHOTECH CORP$6,144,0002,400,000
+100.0%
0.78%
NTRI NewNUTRI SYS INC NEW$5,205,000100,000
+100.0%
0.66%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$4,585,000
+132.6%
282,000
+120.3%
0.58%
+43.5%
BJRI NewBJS RESTAURANTS INC$4,023,000108,000
+100.0%
0.51%
AVEO SellAVEO PHARMACEUTICALS INC$3,552,000
+25.4%
1,600,000
-66.7%
0.45%
-22.6%
BURL NewBURLINGTON STORES INC$3,312,00036,000
+100.0%
0.42%
SFS NewSMART & FINAL STORES INC$3,312,000364,000
+100.0%
0.42%
OSTK NewOVERSTOCK COM INC DEL$2,999,000184,000
+100.0%
0.38%
AVXS NewAVEXIS INC$2,958,00036,000
+100.0%
0.38%
BLUE BuyBLUEBIRD BIO INC$2,941,000
+34.8%
28,000
+16.7%
0.38%
-16.9%
EYEG NewEYEGATE PHARMACEUTICALS INC$2,214,0001,616,000
+100.0%
0.28%
CERC NewCERECOR INC$1,939,0003,384,224
+100.0%
0.25%
TLRDQ SellTAILORED BRANDS INC$1,674,000
-61.1%
150,000
-47.9%
0.21%
-76.0%
JILL NewJ JILL INC$1,622,000132,000
+100.0%
0.21%
DYNT  DYNATRONICS CORP$1,400,000
-1.8%
500,0000.0%0.18%
-39.5%
ATEC SellALPHATEC HOLDINGS INC$992,000
-21.5%
536,414
-1.1%
0.13%
-51.7%
AVIR NewAVIRAGEN THERAPEUTICS INC$752,0001,122,829
+100.0%
0.10%
ZFGN ExitZAFGEN INC$0-112,000
-100.0%
-0.11%
PDLI ExitPDL BIOPHARMA INC$0-500,000
-100.0%
-0.23%
ARLZ ExitARALEZ PHARMACEUTICALS INC$0-700,000
-100.0%
-0.31%
TLRDQ ExitTAILORED BRANDS INCcall$0-160,000
-100.0%
-0.49%
WSM ExitWILLIAMS SONOMA INC$0-52,000
-100.0%
-0.58%
DFRG ExitDEL FRISCOS RESTAURANT GROUP$0-240,000
-100.0%
-0.90%
DKS ExitDICKS SPORTING GOODS INC$0-100,000
-100.0%
-1.00%
ABUS ExitARBUTUS BIOPHARMA CORP$0-1,600,000
-100.0%
-1.07%
SAM ExitBOSTON BEER INCcl a$0-54,000
-100.0%
-1.61%
VSTO ExitVISTA OUTDOOR INC$0-450,000
-100.0%
-1.91%
DECK ExitDECKERS OUTDOOR CORP$0-172,000
-100.0%
-2.12%
KATE ExitKATE SPADE & CO$0-572,000
-100.0%
-2.74%
WFM ExitWHOLE FOODS MKT INCcall$0-700,000
-100.0%
-4.30%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q2 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (784655000.0 != 784656000.0)

Export ARMISTICE CAPITAL, LLC's holdings